Zeke Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | $866K | Sell |
12,034
-851
| -7% | -$61.2K | 0.06% | 159 |
|
2022
Q3 | $916K | Sell |
12,885
-19
| -0.1% | -$1.35K | 0.07% | 130 |
|
2022
Q2 | $994K | Buy |
12,904
+859
| +7% | +$66.2K | 0.07% | 126 |
|
2022
Q1 | $879K | Buy |
+12,045
| New | +$879K | 0.04% | 156 |
|
2020
Q1 | – | Sell |
-18,557
| Closed | -$1.19M | – | 273 |
|
2019
Q4 | $1.19M | Buy |
18,557
+11,038
| +147% | +$708K | 0.1% | 169 |
|
2019
Q3 | $381K | Sell |
7,519
-18,757
| -71% | -$950K | 0.03% | 407 |
|
2019
Q2 | $1.19M | Sell |
26,276
-76
| -0.3% | -$3.45K | 0.11% | 155 |
|
2019
Q1 | $1.26M | Sell |
26,352
-1,715
| -6% | -$81.8K | 0.12% | 149 |
|
2018
Q4 | $1.46M | Buy |
28,067
+5,095
| +22% | +$265K | 0.14% | 132 |
|
2018
Q3 | $1.43M | Sell |
22,972
-1,884
| -8% | -$117K | 0.12% | 161 |
|
2018
Q2 | $1.38M | Sell |
24,856
-19,071
| -43% | -$1.06M | 0.13% | 136 |
|
2018
Q1 | $2.78M | Buy |
43,927
+10,675
| +32% | +$675K | 0.26% | 70 |
|
2017
Q4 | $2.04M | Buy |
33,252
+2,283
| +7% | +$140K | 0.21% | 78 |
|
2017
Q3 | $1.97M | Buy |
30,969
+15,189
| +96% | +$968K | 0.27% | 64 |
|
2017
Q2 | $879K | Buy |
15,780
+1,814
| +13% | +$101K | 0.17% | 78 |
|
2017
Q1 | $759K | Buy |
13,966
+1,091
| +8% | +$59.3K | 0.16% | 74 |
|
2016
Q4 | $752K | Buy |
12,875
+7,050
| +121% | +$412K | 0.2% | 57 |
|
2016
Q3 | $287K | Buy |
+5,825
| New | +$287K | 0.13% | 59 |
|
2015
Q2 | – | Sell |
-3,313
| Closed | -$214K | – | 52 |
|
2015
Q1 | $214K | Buy |
+3,313
| New | +$214K | 0.17% | 62 |
|
2014
Q1 | – | Sell |
-4,507
| Closed | -$240K | – | 59 |
|
2013
Q4 | $240K | Hold |
4,507
| – | – | 0.22% | 50 |
|
2013
Q3 | $209K | Sell |
4,507
-500
| -10% | -$23.2K | 0.2% | 54 |
|
2013
Q2 | $224K | Buy |
+5,007
| New | +$224K | 0.18% | 38 |
|